ec2
 

Clive
Spiegler

Clive Spiegler currently acts as Senior Director of New Product Planning for UCB Celltech in the United Kingdom.

Clive Spiegler boasts a career that spans 18 years in the research, development, and marketing of pharmaceuticals that treat conditions afflicting millions worldwide. As Senior Director for New Product Planning at the British branch of Brussels-based pharmaceutical giant UCB, S.A., Clive Spiegler oversees the life-cycle strategy and marketing for early-phase immunology pipeline products, including evaluating in-licensing opportunities. The company’s research efforts focus on the development of treatments for severe immunological and central nervous system disorders.

Clive Spiegler is a core member of UCB Celltech’s Immunology Therapeutic Area Strategy Team and was integral to the development of the life-cycle strategic plan for the company’s new anti-IL6 antibody. Clive Spiegler has earned degrees from respected institutions in England, France, and Switzerland, including his Ph.D. in Organic Chemistry from the University of Zurich.

Since that time, Clive Spiegler has shared in a number of patents in the U.S. and Europe, and played an instrumental role in the development and management of a number of programs for major pharmaceutical companies including F. Hoffman-La Roche, Ltd., Abbott Laboratories, Knoll Pharmaceutical Company, and UCB Celltech.

Projects that Clive Spiegler has taken on include such groundbreaking products as Invirase and Fortovase, Humira, and most recently Cimzia, UCB’s latest treatment for rheumatoid arthritis and related inflammatory immunological disorders, such as Crohn’s disease. In addition to his work at UCB Celltech, Clive Spiegler is a competitive marathon runner and enjoys cooking a wide variety of cuisines for friends and family.


Clive Spiegler's Schools

  		•  University of Zurich , Class of 1993
    Ph.D
  		• Faculte de Pharmacie, Strasbourg , Class of 1989
    MA

    Top of the year with Mention Tres Bien
    Project sponsored by Perstorp Pharma
  		• Surrey University , Class of 1988
    Bachelors

    1st Class Honours Degree
    I spent my industrial year (3rd year) working in France. I spend the first 6 months working for Alcon in Kaysersberg and then 6 months working in the Department of Analytical Chemistry at the School of Pharmacy in Strasbourg

Clive Spiegler's Companies

  		•  UCB Celltech 2005
    Senior Director New Product Planning
  		• Abbott Laboratories 2001 - 2003
    Global Project Head
    Won 3 presidents awards and 1 chairmans award while working at Abbott Laboratories Honors Employees for Superior Performance